Baker Brothers Advisors - G1 THERAPEUTICS INC ownership

G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 73 filers reported holding G1 THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.13 and the average weighting 0.0%.

Quarter-by-quarter ownership
Baker Brothers Advisors ownership history of G1 THERAPEUTICS INC
ValueSharesWeighting
Q1 2020$970,000
-71.2%
88,026
-30.8%
0.01%
-66.7%
Q4 2019$3,363,000
+16.0%
127,2360.0%0.02%
-10.0%
Q3 2019$2,898,000
-25.7%
127,2360.0%0.02%
-25.9%
Q2 2019$3,901,000
+84.7%
127,2360.0%0.03%
+92.9%
Q1 2019$2,112,000
-13.3%
127,2360.0%0.01%
-30.0%
Q4 2018$2,437,000
-63.4%
127,2360.0%0.02%
-54.5%
Q3 2018$6,653,000
-9.7%
127,236
-24.9%
0.04%
-20.0%
Q2 2018$7,366,000
+17.3%
169,4920.0%0.06%
+3.8%
Q1 2018$6,280,000169,4920.05%
Other shareholders
G1 THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Birchview Capital, LP 120,000$172,8000.15%
DENALI ADVISORS LLC 148,800$214,2720.08%
XTX Topco Ltd 296,601$427,1050.07%
NEEDHAM INVESTMENT MANAGEMENT LLC 234,000$336,9600.06%
LEVEL FOUR ADVISORY SERVICES, LLC 183,400$264,0960.02%
Curi Wealth Management, LLC 70,742$101,8690.02%
FRANKLIN STREET ADVISORS INC /NC 83,400$1200.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 140,000$201,6000.01%
JACOBS LEVY EQUITY MANAGEMENT, INC 573,256$825,4890.01%
ALGERT GLOBAL LLC 68,100$980.01%
View complete list of G1 THERAPEUTICS INC shareholders